What is known and objective: The complex dose regimens of the direct-acting oral anticoagulants (DOAC) make their appropriate prescribing highly challenging. Inappropriate prescribing of the DOAC remains poorly addressed. We studied the patterns of DOAC prescription and estimated the prevalence of drug-related problems (DRPs) associated with their use. Methods: A cross-sectional study was conducted using data from medical records system of the Lyon teaching hospitals. DRPs, identified among patients who received a DOAC, between 1 January 2010 and 31 July 2013, were categorized according to the Pharmaceutical Care Network Europe Classification System. The prevalence of hospital stays with a DRP was estimated, and a subgroup analysis acc...
Introduction: Direct oral anticoagulants (DOACs) are common alternatives to warfarin. Contrary to ma...
Background and Objectives: Appropriate dosing of direct oral anticoagulants (DOACs) is required to a...
Aims: To assess the association between concurrent use of potential pharmacokinetic or pharmacodynam...
cited By 2International audienceWhat is known and objective: The complex dose regimens of the direct...
AIMS: Even though the use of Direct Oral Anticoagulants (DOACs) is safe based on clinical outcomes, ...
PURPOSE This study aimed to estimate the prevalence, contributory factors, and severity of medica...
Abstract Introduction In the past decade, direct-acting oral anticoagulants (DOAC) have been introdu...
International audienceBackground Direct oral anticoagulants (DOACs) account for an increasing propor...
To describe the prevalence and associated factors of inappropriate doses of direct oral anticoagulan...
Direct oral anticoagulants (DOAC) are increasingly used in clinical practice, partly due to their hi...
The use of direct oral anticoagulants (DOAC) is increasing. Specific concentrations are available an...
The significance of this study is to determine the degree of inconsistency in dosing practice of DOA...
Introduction: For years, anticoagulants have been the basic group of drugs that slow down, inhibit o...
Abstract Background For more than a decade, direct oral anticoagulants (DOACs) have been approved in...
The use of direct oral anticoagulants (DOAC) is increasing. Specific concentrations are available an...
Introduction: Direct oral anticoagulants (DOACs) are common alternatives to warfarin. Contrary to ma...
Background and Objectives: Appropriate dosing of direct oral anticoagulants (DOACs) is required to a...
Aims: To assess the association between concurrent use of potential pharmacokinetic or pharmacodynam...
cited By 2International audienceWhat is known and objective: The complex dose regimens of the direct...
AIMS: Even though the use of Direct Oral Anticoagulants (DOACs) is safe based on clinical outcomes, ...
PURPOSE This study aimed to estimate the prevalence, contributory factors, and severity of medica...
Abstract Introduction In the past decade, direct-acting oral anticoagulants (DOAC) have been introdu...
International audienceBackground Direct oral anticoagulants (DOACs) account for an increasing propor...
To describe the prevalence and associated factors of inappropriate doses of direct oral anticoagulan...
Direct oral anticoagulants (DOAC) are increasingly used in clinical practice, partly due to their hi...
The use of direct oral anticoagulants (DOAC) is increasing. Specific concentrations are available an...
The significance of this study is to determine the degree of inconsistency in dosing practice of DOA...
Introduction: For years, anticoagulants have been the basic group of drugs that slow down, inhibit o...
Abstract Background For more than a decade, direct oral anticoagulants (DOACs) have been approved in...
The use of direct oral anticoagulants (DOAC) is increasing. Specific concentrations are available an...
Introduction: Direct oral anticoagulants (DOACs) are common alternatives to warfarin. Contrary to ma...
Background and Objectives: Appropriate dosing of direct oral anticoagulants (DOACs) is required to a...
Aims: To assess the association between concurrent use of potential pharmacokinetic or pharmacodynam...